Anna Dahlman

696 total citations
19 papers, 553 citations indexed

About

Anna Dahlman is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Dahlman has authored 19 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Dahlman's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Prostate Cancer Treatment and Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Anna Dahlman is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Prostate Cancer Treatment and Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Anna Dahlman collaborates with scholars based in Sweden, United States and Denmark. Anna Dahlman's co-authors include Anders Bjartell, Rebecka Hellsten, Olov Sterner, Martin Johansson, Thomas T. Poulsen, Helle J. Jacobsen, Michael Kragh, Ivan D. Horak, Johan Lantto and Mikkel W. Pedersen and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Anna Dahlman

19 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Dahlman Sweden	12	296	217	138	129	121	19	553
David Molkentine United States	16	357 1.2×	371 1.7×	67 0.5×	84 0.7×	186 1.5×	30	708
Astrid Mayer United Kingdom	8	367 1.2×	179 0.8×	109 0.8×	35 0.3×	126 1.0×	14	557
Francis Bichat France	9	223 0.8×	273 1.3×	59 0.4×	49 0.4×	141 1.2×	22	514
Claus Fittschen United States	9	147 0.5×	271 1.2×	52 0.4×	121 0.9×	87 0.7×	18	586
Yao Huang China	13	159 0.5×	161 0.7×	108 0.8×	95 0.7×	225 1.9×	35	613
Weining Ma United States	13	301 1.0×	524 2.4×	152 1.1×	145 1.1×	77 0.6×	25	887
Gerd Leder Germany	11	287 1.0×	212 1.0×	22 0.2×	93 0.7×	55 0.5×	13	526
Vincent A. Pollack United States	9	423 1.4×	219 1.0×	128 0.9×	78 0.6×	228 1.9×	12	660
Sofia Genta Canada	12	434 1.5×	289 1.3×	66 0.5×	170 1.3×	139 1.1×	36	742
Martin H. Goldrosen United States	16	272 0.9×	160 0.7×	99 0.7×	283 2.2×	40 0.3×	53	626

Countries citing papers authored by Anna Dahlman

Since Specialization

Citations

This map shows the geographic impact of Anna Dahlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dahlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dahlman more than expected).

Fields of papers citing papers by Anna Dahlman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Dahlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dahlman. The network helps show where Anna Dahlman may publish in the future.

Co-authorship network of co-authors of Anna Dahlman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Dahlman. A scholar is included among the top collaborators of Anna Dahlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Dahlman. Anna Dahlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Dahlman, Anna, et al.. (2021). A novel care guide for personalised palliative care – a national initiative for improved quality of care. BMC Palliative Care. 20(1). 176–176. 6 indexed citations

Dahlman, Anna, Manoj Puthia, Jitka Petrlová, Artur Schmidtchen, & Ganna Petruk. (2021). Thrombin-Derived C-Terminal Peptide Reduces Candida -Induced Inflammation and Infection In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 65(11). e0103221–e0103221. 10 indexed citations

Kvarnhammar, Anne Månsson, Niina Veitonmäki, Karin Hägerbrand, et al.. (2019). The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. Journal for ImmunoTherapy of Cancer. 7(1). 103–103. 89 indexed citations

Dahlman, Anna, Michelle H. Nelson, Anneli Nilsson, et al.. (2019). Abstract 2380: Preclinical safety and efficacy of a tumor-directed T cell activating 4-1BB x 5T4 ADAPTIR™ bispecific antibody. Cancer Research. 79(13_Supplement). 2380–2380. 2 indexed citations

Dahlén, Eva, et al.. (2019). Abstract A183: ATOR-1017: A 4-1BB antibody designed for superior safety/efficacy profile in cancer immunotherapy. Cancer Immunology Research. 7(2_Supplement). A183–A183. 1 indexed citations

Poulsen, Thomas T., Michael M. Grandal, Klaus Koefoed, et al.. (2017). Sym015: A Highly Efficacious Antibody Mixture against MET -Amplified Tumors. Clinical Cancer Research. 23(19). 5923–5935. 42 indexed citations

Grandal, Michael M., Thomas T. Poulsen, Klaus Koefoed, et al.. (2017). Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms. Molecular Cancer Therapeutics. 16(12). 2780–2791. 23 indexed citations

Jacobsen, Helle J., Thomas T. Poulsen, Anna Dahlman, et al.. (2015). Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity. Clinical Cancer Research. 21(18). 4110–4122. 71 indexed citations

Pedersen, Mikkel W., Helle J. Jacobsen, Klaus Koefoed, et al.. (2015). Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance. Molecular Cancer Therapeutics. 14(3). 669–680. 42 indexed citations

10.

Nielsen, Carsten H., Mette Munk Jensen, Lotte K. Kristensen, et al.. (2015). In vivoimaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography. Oncotarget. 6(35). 37486–37499. 12 indexed citations

11.

Hoogland, A. Marije, Anna Dahlman, Kees J. Vissers, et al.. (2011). Cysteine‐rich secretory protein 3 and β‐microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome. British Journal of Urology. 108(8). 1356–1362. 6 indexed citations

12.

Hellsten, Rebecka, Martin Johansson, Anna Dahlman, Olov Sterner, & Anders Bjartell. (2011). Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells. PLoS ONE. 6(7). e22118–e22118. 72 indexed citations

13.

Dahlman, Anna, Elton Rexhepaj, Donal J. Brennan, et al.. (2011). Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis. Modern Pathology. 24(5). 708–719. 29 indexed citations

14.

Dahlman, Anna, Anders Edsjö, Christer Halldén, et al.. (2010). Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3. Prostate Cancer and Prostatic Diseases. 13(4). 369–375. 26 indexed citations

15.

Wang, Baofeng, Peter Hammarsten, Anna Dahlman, et al.. (2010). LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer. International Journal of Cancer. 128(12). 2843–2852. 34 indexed citations

16.

Hellsten, Rebecka, Martin Johansson, Anna Dahlman, et al.. (2007). Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3. The Prostate. 68(3). 269–280. 62 indexed citations

17.

Dahlman, Anna, Esbjörn Telemo, S. Ahlstedt, et al.. (1994). Immune Response against Ovalbumin in Rats Colonized with an Ovalbumin-Producing <i>Escherichia coli</i> and the Influence of Feeding Ovalbumin. International Archives of Allergy and Immunology. 105(4). 381–385. 6 indexed citations

18.

Hanson, Lars, Esbjörn Telemo, Ursula Wiedermann, et al.. (1993). Sensitization and development of tolerance via the gut. Pediatric Allergy and Immunology. 4(S3). 16–20. 8 indexed citations

19.

Dahlman, Anna, S. Ahlstedt, Lars Hanson, et al.. (1992). Induction of IgE antibodies and T-cell reactivity to ovalbumin in rats colonized with Escherichia coli genetically manipulated to produce ovalbumin.. PubMed. 76(2). 225–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact